Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2018

Every FDA drug recall initiated in 2018, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,681 recalls, newest first.

Class III · Low risk

Fluconazole Injection

Superpotent Drug and Failed Stability Specifications: lot out of specification for elevated sodium chloride and elevated water vapor.

Terminated Wrong potency / content Renaissance Lakewood, LLC NDC 36000-003-06 D-1031-2018
Class III · Low risk

Diazepam Rectal Gel

Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton.

Terminated Labeling / mix-up Valeant Pharmaceuticals North America LLC NDC 68682-650-20 D-1041-2018
Class II · Moderate risk

Admelog Solostar

Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.

Ongoing Temperature excursion Sanofi-Aventis U.S. LLC NDC 0024-5925-00 D-0925-2018
Class II · Moderate risk

Fluocinolone Acetonide Topical Solution

Failed Impurities and Degradation Specifications and Subpotent Drug: out-of-specification (OOS) test results for below assay and above specification for degradants.

Terminated Impurity / degradation Teva Pharmaceuticals USA NDC 0591-2990-60 D-0909-2018
Class II · Moderate risk

Metformin Hydrochloride Extended Release Tablets

Presence of foreign substance: One lot fo Metformin Hydrochloride Extended Release Tablets, USP, 500 mg (500 Count) contains foreign matter identified as a piece of rubber glove detected in one tablet.

Terminated Particulate / foreign matter Sun Pharmaceutical Industries, Inc. NDC 62756-142-02 D-0924-2018
Class II · Moderate risk

Monsel's Solution

CGMP Deviations: The manufacturer of this product recalled because they were not manufactured under current good manufacturing practices.

Terminated cGMP deviation Medgyn Products, Inc. NDC 42721-112-08 D-0917-2018
Class I · High risk

Neostigmine Methylsulfate Injection Solution

Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.

Terminated Labeling / mix-up Fagron Compounding Services LLC dba Fagron Sterile Services NDC 71266-2003-01 D-0911-2018
Class I · High risk

Neostigmine Methylsulfate Injection Solution

Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.

Terminated Labeling / mix-up Fagron Compounding Services LLC dba Fagron Sterile Services NDC 71266-2003-02 D-0910-2018
Class II · Moderate risk

Daptomycin for Injection

Microbial Contamination of Sterile Products: Product associated with reports of adverse events indicative of infusion reactions related to microbiological contamination.

Terminated Microbial contamination Pfizer NDC 0409-0106-01 D-1023-2018
Class III · Low risk

Enalapril Maleate

Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

Terminated Impurity / degradation Aidarex Pharmaceuticals LLC D-0992-2018
Class III · Low risk

Enalapril Maleate

Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

Terminated Impurity / degradation Aidarex Pharmaceuticals LLC D-0991-2018
Class III · Low risk

Enalapril Maleate

Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.

Terminated Impurity / degradation Aidarex Pharmaceuticals LLC D-0990-2018
Class I · High risk

Blissful Remedies

Microbial Contamination of Non-Sterile Products: The firm is initiating a recall of some of its products due to the potential of high microbial loads.

Terminated Microbial contamination World Organix, LLC D-1123-2018
Class I · High risk

Blissful Remedies Red Maeng Da

Microbial Contamination of Non-Sterile Products: The firm is initiating a recall of some of its products due to the potential of high microbial loads.

Terminated Microbial contamination World Organix, LLC D-1122-2018
Class III · Low risk

Enalapril Maleate Tablets

Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product.

Terminated Impurity / degradation Major Pharmaceuticals NDC 0904-5502-61 D-0980-2018
Class III · Low risk

Enalapril Maleate Tablets

Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product.

Terminated Impurity / degradation Major Pharmaceuticals NDC 0904-5609-61 D-0979-2018

Recalls by year